معرفی
Dongying Chen, MD, PhD, is an Associate Research Scientist in the Department of Cardiovascular Medicine at the Yale School of Medicine. Her research focuses on endothelial cell biology, vascular development, and the molecular mechanisms regulating cardiovascular systems. She holds a PhD in Cell and Developmental Biology from Thomas Jefferson University and MD from Sun Yat-Sen University of Medical Sciences. Dr. Chen's work explores ECM interactions in aortic arch development, PLCγ signaling in endothelial function, and arterial fate specification during embryogenesis. She collaborates extensively with researchers like Michael Simons and Anne Eichmann on projects involving vascular permeability, tumor immunity, and lipid metabolism. Her recent studies highlight the role of chylomicrons in intestinal lipid absorption and VEGFR2-driven anti-tumor immunity mechanisms.
Key research interests include cell-ECM signaling pathways, developmental cardiovascular biology, and translational studies linking endothelial function to disease. Her work bridges developmental biology with clinical applications in cardiovascular medicine, leveraging interdisciplinary approaches to understand vascular pathophysiology.
